Pharmacology and Toxicology
Showing page 14 of 23 pages of list content
-
Ribavirin shows antiviral activity against SARS-CoV-2 and downregulates the activity of TMPRSS2 and the expression of ACE2 In Vitro
This article's authors -
Discovery of Clioquinol and Analogues as Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection, ACE2 and ACE2 - Spike Protein Interaction In Vitro
This article's authors -
Small-Molecule In Vitro Inhibitors of the Coronavirus Spike – ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2
This article's authors -
In Vivo Pharmacokinetic Study of Remdesivir Dry Powder for Inhalation in Hamsters
This article's authors -
Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mice Models
This article's authors -
A comparison of Remdesivir versus Au 22 Glutathione 18 in COVID-19 golden hamsters: a better therapeutic outcome of gold compound
This article's authors -
Losartan promotes cell survival following SARS-CoV-2 infection in vitro
This article's authors -
Combined in silico docking and in vitro antiviral testing for drug repurposing identified lurasidone and elbasvir as SARS-CoV-2 and HCoV-OC43 inhibitors
This article's authors -
An expedited approach towards the rationale design of non-covalent SARS-CoV-2 main protease inhibitors with in vitro antiviral activity
This article's authors -
Genetic determinants of COVID-19 drug efficacy revealed by genome-wide CRISPR screens
This article's authors